Rebuilding nature. Rebuilding life.

Company Profile


InSCREENeX's technologies allow the generation of individual cellular material for all stages of the drug development process. SCREENflex is a platform technology to establish stable cell lines for primary screening – fast, flexible and predictable. The CI-SCREEN technology was developed to get access to unlimited amounts of tissue like cells – of any desired origin and species.

On the basis of these technologies InSCREENeX offers pharmaceutical and biotech companies optimal tools to develop new drugs under »in vivo« conditions – adapted to in vitro set ups.

InSCREENeX GmbH is a spin-off of the Helmholtz Centre for Infection Research.
The founder is Dr. rer. nat. Roland Schucht.